NOW Investigated for MRC Global Merger and Turnstone Biologics Acquisition Shareholder Rights

Investor Rights Firm Investigates MRC Global and Turnstone Biologics Transactions

Halper Sadeh LLC, a law firm specializing in investor rights, is currently investigating potential violations of federal securities laws and breaches of fiduciary duties related to the proposed sale of MRC Global Inc. to DNOW Inc. and the acquisition of Turnstone Biologics Corp. by XOMA Royalty Corporation. This scrutiny arises amidst significant corporate transactions that could potentially affect shareholder interests. In the case of MRC Global, shareholders are set to receive 0.9489 shares of DNOW common stock for each share they own, resulting in DNOW shareholders controlling approximately 56.5% of the new entity post-merger. The law firm aims to ensure that shareholders are adequately informed and compensated during this transition, highlighting the importance of transparency in corporate mergers and acquisitions.

In parallel, Halper Sadeh LLC is also focusing on the acquisition of Turnstone Biologics, which is being sold to XOMA Royalty Corporation for $0.34 per share in cash, supplemented by a non-transferable contingent value right. This transaction raises similar concerns about shareholder rights and the adequacy of disclosure provided by Turnstone's management. The firm emphasizes the need for proper communication regarding these financial moves, as it is critical for shareholders to understand the implications of such sales and the value of their investments. By investigating both transactions, Halper Sadeh LLC advocates for the rights of shareholders who may feel overlooked during significant corporate shifts.

The law firm operates on a contingency fee basis, allowing shareholders to pursue legal action without incurring upfront costs. This model is particularly appealing to investors who may be apprehensive about the financial implications of seeking legal redress. Halper Sadeh LLC invites shareholders from both MRC Global and Turnstone Biologics to reach out for a free consultation to explore their legal rights and options. With a proven track record of recovering millions for defrauded investors, the firm is committed to protecting shareholder interests and ensuring accountability in corporate governance.

In addition to its current investigations, Halper Sadeh LLC continues to build its reputation as a defender of investor rights on a global scale. The firm’s focus on securities fraud and corporate misconduct positions it as a vital resource for shareholders seeking justice. Interested parties can find contact information for attorneys Daniel Sadeh and Zachary Halper, who are ready to assist those affected by these corporate transactions. The ongoing investigations underscore the critical role that law firms play in navigating the complexities of corporate mergers and safeguarding shareholder interests.